Regulation of Plasma Low Density Lipoprotein Levels Biopharmacological Regulation of Protein Phosphorylation Calcium-Activated Neutral Protease Microbial Iron Transport Pharmacokinetic Drug Interactions

Erscheinungsjahr 2012
ISBN: 978-3-642-72902-7
Verlag: Springer
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, Band 5, 134 Seiten, eBook

Reihe: Progress in Clinical Biochemistry and Medicine

Cholesterol is essential for normal cellular function. It is found in all cells of the body and is a major constituent of cell membranes. In addition, certain specialized tissues use cholesterol as the basic substrate for the synthesis of more complicated sterols such as bile acids and the steroid hormones. Like most lipids cholesterol has a very low solubility in water. Therefore, in order for these molecules to be transported be tween different organs of the body a series of lipid carriers known as lipoproteins has evolved. Over the last several years epidemiological evidence has accumulated suggest ing a strong relationship between the risk of atherosclerosis and high plasma concen trations of one of these lipoproteins, low density lipoprotein (LDL) 1). Thus, in popula tions with high plasma concentrations of LDL-cholesterol a correspondingly high incidence of vascular disease is seen. Since it has been demonstrated that reducing the steady-state plasma LDL-cholesterol concentration produces a proportional decrease in the risk of developing atherosclerosis 2), a major effort is now underway to develop safe and effective lipid lowering agents. In the past, these efforts have been hampered by a lack of knowledge concerning the physiological regulation of the plasma LDL-cholesterol concentration. However, recently there have been several major advances in these areas and it is now possible to precisely determine those factors that have the greatest effect on either increasing or decreasing the plasma LDL-cholesterol concentration.

Zielgruppe

Research

Autoren/Hrsg.

Weitere Mitwirkende

Bartle, William R.

Braun, Volker

Dietschy, John M.

Emori, Yasufumi

Hagiwara, Masatoshi

Hidaka, Hiroyoshi

Imajoh, Shinobu

Kawasaki, Hiroshi

Meddings, Jonathan B.

Ohno, Shigeo

Suzuki, Koichi

Walker, Scott E.

Winkelmann, Günther

Winslade, Nancy E.

Inhaltsverzeichnis

Regulation of Plasma Low Density Lipoprotein Levels: New Strategies for Drug Design.- Biopharmacological Regulation of Protein Phosphorylation.- Calcium-Activated Neutral Protease (CANP) and its Biological and Medical Implications.- Microbial Iron Transport — Structure and Function of Siderophores.- Pharmacokinetic Drug Interactions.- Author Index Volumes 1–5.